ADVERTISEMENT

Psychedelics News

Seelos Therapeutics

Industry

21 Sep 2023

Seelos Therapeutics Announces Results from Phase II Depression Trial

Seelos Therapeutics has released results from its SLS-002 Phase II study of adults with Major Depressive Disorder at Imminent Risk of Suicide....

By Microdose NewsDesk

Don’t Miss

29 Aug 2022

News You Might Have Missed: Aug 29th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

8 Mar 2022

Seelos Therapeutics: Year-End Results and Business Highlights

Even if not on most people’s sexiest shroom stock list, Seelos Therapeutics has been a solid presence in the psychedelic medicine space for some time....

By Jason Najum

Industry

26 Nov 2021

Seelos Raises $20M, Acquires Ketamine Tech, and Announces New Drug

This week Seelos released several pieces of important news: they raised $20 million in capital, acquired a worldwide license for sublingual ketamine delivery technology, and announced the evaluation of a...

By Jason Najum

ADVERTISEMENT

Follow us on social

Latest News

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads